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Abstract
This work introduces a method to tune a sequence-based generative model for molecular de novo design that
through augmented episodic likelihood can learn to generate structures with certain specified desirable properties.
We demonstrate how this model can execute a range of tasks such as generating analogues to a query structure
and generating compounds predicted to be active against a biological target. As a proof of principle, the model is
first trained to generate molecules that do not contain sulphur. As a second example, the model is trained to
generate analogues to the drug Celecoxib, a technique that could be used for scaffold hopping or library
expansion starting from a single molecule. Finally, when tuning the model towards generating compounds
predicted to be active against the dopamine receptor type 2, the model generates structures of which more than
95% are predicted to be active, including experimentally confirmed actives that have not been included in either
the generative model nor the activity prediction model.
Keywords: De Novo design; Recurrent Neural Networks; Reinforcement Learning
1 Introduction
Drug discovery is often described using the metaphor of
finding a needle in a haystack. In this case, the haystack
comprises on the order of 1060 − 10100 synthetically
feasible molecules [1], out of which we need to find a
compound which satisfies the plethora of criteria such
as bioactivity, drug metabolism and pharmacokinetic
(DMPK) profile, synthetic accessibility, etc. The frac-
tion of this space that we can synthesize and test at all
- let alone efficiently - is negligible. By using algorithms
to virtually design and assess molecules, de novo design
offers ways to reduce the chemical space into something
more manageable for the search of the needle.
Early de novo design algorithms [1] used structure
based approaches to grow ligands to sterically and
electronically fit the binding pocket of the target of
interest [2, 3]. A limitation of these methods is that the
molecules created often possess poor DMPK properties
and can be synthetically intractable. In contrast, the
ligand based approach is to generate a large virtual
library of chemical structures, and search this chemi-
cal space using a scoring function that typically takes
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into account several properties such as DMPK profiles,
synthetic accessibility, bioactivity, and query structure
similarity [4, 5]. One way to create such a virtual li-
brary is to use known chemical reactions alongside a
set of available chemical building blocks, resulting in
a large number of synthetically accessible structures
[6]; another possibility is to use transformational rules
based on the expertise of medicinal chemists to design
analogues to a query structure. For example, Besnard
et al. [7] applied a transformation rule approach to
the design of novel dopamine receptor type 2 (DRD2)
receptor active compounds with specific polypharma-
cological profiles and appropriate DMPK profiles for
a central nervous system indication. Although using
either transformation or reaction rules can reliably and
effectively generate novel structures, they are limited
by the inherent rigidness and scope of the predefined
rules and reactions.
A third approach, known as inverse Quantitative
Structure Activity Relationship (inverse QSAR), tack-
les the problem from a different angle: rather than first
generating a virtual library and then using a QSAR
model to score and search this library, inverse QSAR
aims to map a favourable region in terms of predicted
activity to the corresponding molecular structures [8–
10]. This is not a trivial problem: first the solutions
of molecular descriptors corresponding to the region
need to be resolved using the QSAR model, and these
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then need be mapped back to the corresponding molec-
ular structures. The fact that the molecular descriptors
chosen need to be suitable both for building a forward
predictive QSAR model as well as for translation back
to molecular structure is one of the major obstacles for
this type of approach.
The Recurrent Neural Network (RNN) is commonly
used as a generative model for data of sequential na-
ture, and have been used successfully for tasks such as
natural language processing [11] and music generation
[12]. Recently, there has been an increasing interest in
using this type of generative model for the de novo
design of molecules [13–15]. By using a data-driven
method that attempts to learn the underlying probabil-
ity distribution over a large set of chemical structures,
the search over the chemical space can be reduced to
only molecules seen as reasonable, without introduc-
ing the rigidity of rule based approaches. Segler et al.
demonstrated that an RNN trained on the canonical-
ized SMILES representation of molecules can learn both
the syntax of the language as well as the distribution in
chemical space [13]. They also show how further train-
ing of the model using a focused set of actives towards a
biological target can produce a fine-tuned model which
generates a high fraction of predicted actives.
In two recent studies, reinforcement learning (RL)
[16] was used to fine tune pre-trained RNNs. Yu et al.
[15] use an adversarial network to estimate the expected
return for state-action pairs sampled from the RNN,
and by increasing the likelihood of highly rated pairs
improves the generative network for tasks such as poem
generation. Jaques et al. [17] use Deep Q-learning to
improve a pre-trained generative RNN by introducing
two ways to score the sequences generated: one is a
measure of how well the sequences adhere to music
theory, and one is the likelihood of sequences accord-
ing to the initial pre-trained RNN. Using this concept
of prior likelihood they reduce the risk of forgetting
what was initially learnt by the RNN, compared to a
reward based only on the adherence to music theory.
The authors demonstrate significant improvements over
both the initial RNN as well as an RL only approach.
They later extend this method to several other tasks
including the generation of chemical structures, and
optimize toward molecular properties such as cLogP
[18] and QED drug-likeness [19]. However, they report
that the method is dependent on a reward function
incorporating handwritten rules to penalize undesir-
able types of sequences, and even then can lead to
exploitation of the reward resulting in unrealistically
simple molecules that are more likely to satisfy the op-
timization requirements than more complex structures
[17].
In this study we propose a policy based RL approach
to tune RNNs for episodic tasks [16], in this case the
task of generating molecules with given desirable prop-
erties. Through learning an augmented episodic likeli-
hood which is a composite of prior likelihood [17] and a
user defined scoring function, the method aims to fine-
tune an RNN pre-trained on the ChEMBL database [20]
towards generating desirable compounds. Compared
to maximum likelihood estimation finetuning [13], this
method can make use of negative as well as continuous
scores, and may reduce the risk of catastrophic forget-
ting [21]. The method is applied to several different
tasks of molecular de novo design, and an investigation
was carried out to illustrate how the method affects
the behaviour of the generative model on a mechanistic
level.
2 Methods
2.1 Recurrent Neural Networks
A recurrent neural network is an architecture of neural
networks designed to make use of the symmetry across
steps in sequential data while simultaneously at every
step keeping track of the most salient information of
previously seen steps, which may affect the interpreta-
tion of the current one [22]. It does so by introducing
the concept of a cell (Figure 1). For any given step
t, the cellt is a result of the previous cellt−1 and the
current input xt−1. The content of cellt will determine
both the output at the current step as well as influence
the next cell state. The cell thus enables the network to
have a memory of past events, which can be used when
deciding how to interpret new data. These properties
make an RNN particularly well suited for problems in
the domain of natural language processing. In this set-
ting, a sequence of words can be encoded into one-hot
vectors the length of our vocabulary X. Two additional
tokens, GO and EOS, may be added to denote the
beginning and end of the sequence respectively.
2.1.1 Learning the data
Training an RNN for sequence modeling is typically
done by maximum likelihood estimation of the next
token xt in the target sequence given tokens for the
previous steps (Figure 1). At every step the model will
produce a probability distribution over what the next
character is likely to be, and the aim is to maximize
the likelihood assigned to the correct token:
J(Θ) = −
T∑
t=1
logP (xt | xt−1, ..., x1)
The cost function J(Θ), often applied to a subset of all
training examples known as a batch, is minimized with
respect to the network parameters Θ. Given a predicted
log likelihood logP of the target at step t, the gradient
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Figure 1 Learning the data. Depiction of maximum likelihood
training of an RNN. xt are the target sequence tokens we are
trying to learn by maximizing P (xt) for each step.
of the prediction with respect to Θ is used to make an
update of Θ. This method of fitting a neural network
is called back-propagation. Due to the architecture of
the RNN, changing the network parameters will not
only affect the direct output at time t, but also affect
the flow of information from the previous cell into the
current one iteratively. This domino-like effect that the
recurrence has on back-propagation gives rise to some
particular problems, and back-propagation applied to
RNNs is referred to as back-propagation through time
(BPTT).
BPTT is dealing with gradients that through the
chain-rule contains terms which are multiplied by them-
selves many times, and this can lead to a phenomenon
known as exploding and vanishing gradients. If these
terms are not unity, the gradients quickly become ei-
ther very large or very small. In order to combat this
issue, Hochreiter et al. introduced the Long-Short-Term
Memory cell [23], which through a more controlled flow
of information can decide what information to keep
and what to discard. The Gated Recurrent Unit is
a simplified implementation of the Long-Short-Term
Memory architecture that achieves much of the same
effect at a reduced computational cost [24].
2.1.2 Generating new samples
Once an RNN has been trained on target sequences, it
can then be used to generate new sequences that follow
the conditional probability distributions learned from
the training set. The first input - the GO token - is
given and at every timestep after we sample an output
token xt from the predicted probability distribution
P (Xt) over our vocabulary X and use xt as our next
input. Once the EOS token is sampled, the sequence
is considered finished (Figure 2).
2.1.3 Tokenizing and one-hot encoding SMILES
A SMILES [25] represents a molecule as a sequence of
characters corresponding to atoms as well as special
characters denoting opening and closure of rings and
branches. The SMILES is, in most cases, tokenized
Cellt=1
x1
GO
Cellt=2
x2
Cellt=3
x3
Cellt=4
EOS
Figure 2 Generating sequences. Sequence generation by a
trained RNN. Every timestep t we sample the next token of the
sequence xt from the probability distribution given by the RNN,
which is then fed in as the next input.
based on a single character, except for atom types
which comprise two characters such as ”Cl” and ”Br”
and special environments denoted by square brackets
(e.g [nH]), where they are considered as one token. This
method of tokenization resulted in 86 tokens present in
the training data. Figure 3 exemplifies how a chemical
structure is translated to both the SMILES and one-hot
encoded representations.
There are many different ways to represent a single
molecule using SMILES. Algorithms that always rep-
resent a certain molecule with the same SMILES are
referred to as canonicalization algorithms [26]. How-
ever, different implementations of the algorithms can
still produce different SMILES.
Cl
N
NH
ClCc1c[nH]cn1
Cl C c 1 c nH c n 1
C 0 1 0 0 0 0 0 0 0
c 0 0 1 0 1 0 1 0 0
n 0 0 0 0 0 0 0 1 0
1 0 0 0 1 0 0 0 0 1
nH 0 0 0 0 0 1 0 0 0
Cl 1 0 0 0 0 0 0 0 0
Graph:
SMILES:
One-hot
encoding:
Figure 3 Three representations of
4-(chloromethyl)-1H-imidazole. Depiction of a one-hot
representation derived from the SMILES of a molecule. Here a
reduced vocabulary is shown, while in practice a much larger
vocabulary that covers all tokens present in the training data is
used.
2.2 Reinforcement Learning
Consider an Agent, that given a certain state s ∈ S has
to choose which action a ∈ A(s) to take, where S is
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the set of possible states and A(s) is the set of possible
actions for that state. The policy pi(a | s) of an Agent
maps a state to the probability of each action taken
therein. Many problems in reinforcement learning are
framed as Markov decision processes, which means that
the current state contains all information necessary to
guide our choice of action, and that nothing more is
gained by also knowing the history of past states. For
most real problems, this is an approximation rather
than a truth; however, we can generalize this concept to
that of a partially observable Markov decision process,
in which the Agent can interact with an incomplete
representation of the environment. Let r(a | s) be the
reward which acts as a measurement of how good it was
to take an action at a certain state, and the long-term
return G(at, St =
∑T
t rt as the cumulative rewards
starting from t collected up to time T . Since molecular
desirability in general is only sensible for a completed
SMILES, we will refer only to the return of a complete
sequence.
What reinforcement learning concerns, given a set of
actions taken from some states and the rewards thus
received, is how to improve the Agent policy in such
a way as to increase the expected return E[G]. A task
which has a clear endpoint at step T is referred to as an
episodic task [16], where T corresponds to the length
of the episode. Generating a SMILES is an example of
an episodic task, which ends once the EOS token is
sampled.
The states and actions used to train the agent can
be generated both by the agent itself or by some other
means. If they are generated by the agent itself the
learning is referred to as on-policy, and if they are
generated by some other means the learning is referred
to as off-policy [16].
There are two different approaches often used in
reinforcement learning to obtain a policy: value based
RL, and policy based RL [16]. In value based RL, the
goal is to learn a value function that describes the
expected return from a given state. Having learnt this
function, a policy can be determined in such a way
as to maximize the expected value of the state that a
certain action will lead to. In policy based RL on the
other hand, the goal is to directly learn a policy. For
the problem addressed in this study, we believe that
policy based methods is the natural choice for three
reasons:
• Policy based methods can learn explicitly an opti-
mal stochastic policy [16], which is our goal.
• The method used starts with a prior sequence
model. The goal is to finetune this model accord-
ing to some specified scoring function. Since the
prior model already constitutes a policy, learning a
finetuned policy might require only small changes
to the prior model.
• The episodes in this case are short and fast to
sample, reducing the impact of the variance in the
estimate of the gradients.
In Section 3.4 the change in policy between the prior
and the finetuned model is investigated, providing jus-
tification for the second point.
2.3 The Prior network
Maximum likelihood estimation was employed to train
the initial RNN composed of 3 layers with 1024
Gated Recurrent Units (forget bias 5) in each layer.
The RNN was trained on the RDKit [27] canoni-
cal SMILES of 1.5 million structures from ChEMBL
[20] where the molecules were restrained to contain-
ing between 10 and 50 heavy atoms and elements
∈ {H,B,C,N,O, F, Si, P, S, Cl, Br, I}. The model was
trained with stochastic gradient descent for 50 000 steps
using a batch size of 128, utilizing the Adam optimizer
[28] (β1 = 0.9, β2 = 0.999, and  = 10
−8) with an
initial learning rate of 0.001 and a 0.02 learning rate
decay every 100 steps. Gradients were clipped to [−3, 3].
Tensorflow [29] was used to implement the Prior as well
as the RL Agent.
2.4 The Agent network
We now frame the problem of generating a SMILES
representation of a molecule with specified desirable
properties via an RNN as a partially observable Markov
decision process, where the agent must make a decision
of what character to choose next given the current cell
state. We use the probability distributions learnt by
the previously described prior model as our initial prior
policy. We will refer to the network using the prior pol-
icy simply as the Prior, and the network whose policy
has since been modified as the Agent. The Agent is thus
also an RNN with the same architecture as the Prior.
The task is episodic, starting with the first step of
the RNN and ending when the EOS token is sampled.
The sequence of actions A = a1, a2, ..., aT during this
episode represents the SMILES generated and the prod-
uct of the action probabilities P (A) =
∏T
t=1 pi(at | st)
represents the model likelihood of the sequence formed.
Let S(A) ∈ [−1, 1] be a scoring function that rates
the desirability of the sequences formed using some
arbitrary method. The goal now is to update the agent
policy pi from the prior policy piPrior in such a way
as to increase the expected score for the generated
sequences. However, we would like our new policy to
be anchored to the prior policy, which has learnt both
the syntax of SMILES and distribution of molecular
structure in ChEMBL [13]. We therefore denote an
augmented likelihood logP (A)U as a prior likelihood
modulated by the desirability of a sequence:
logP (A)U = logP (A)Prior + σS(A)
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Agent network
Prior network
Initialize Agent
Scoring function
SMILES strings
SMILES from ChEMBL
Augmented Likelihood
Generate sequences
Update Agent
Likelihood
Figure 4 The Agent. Illustration of how the model is constructed. Starting from a Prior network trained on ChEMBL, the Agent is
trained using the augmented likelihood of the SMILES generated.
where σ is a scalar coefficient. The return G(A) of
a sequence A can in this case be seen as the agree-
ment between the Agent likelihood logP (A)A and the
augmented likelihood:
G(A) = −[logP (A)U − logP (A)A]2
The goal of the Agent is to learn a policy which
maximizes the expected return, achieved by minimiz-
ing the cost function L(Θ) = −G. The fact that
we describe the target policy using the policy of the
Prior and the scoring function enables us to formu-
late this cost function. In the appendix we show
how this approach can be described using a REIN-
FORCE [30] algorithm with a final step reward of
r(t) = [logP (A)U − logP (A)A]2/ logP (A)A. We be-
lieve this is a more natural approach to the problem
than REINFORCE algorithms directly using rewards
of S(A) or logP (A)Prior + σS(A). In Section 3.2 we
compare our approach to these methods. The Agent is
trained in an on-policy fashion on batches of 128 gen-
erated sequences, making an update to pi after every
batch has been generated and scored. A standard gra-
dient descent optimizer with a learning rate of 0.0005
was used and gradients were clipped to [−3, 3].
Figure 4 shows an illustration of how the Agent,
initially identical to the Prior, is trained using rein-
forcement learning. The training shifts the probability
distribution from that of the Prior towards a distribu-
tion modulated by the desirability of the structures.
This method adopts a similar concept to Jaques et
al. [17], while using a policy based RL method that
introduces a novel cost function with the aim of ad-
dressing the need for handwritten rules and the issues
of generating structures that are too simple.
In all the tasks investigated below, the scoring func-
tion is fixed during the training of the Agent. If instead
the scoring function used is defined by a discrimina-
tor network whose task is to distinguish sequences
generated by the Agent from ‘real’ SMILES (e.g. a
set of actives), the method could be described as a
type of Generative Adversarial Network [31], where the
Agent and the discriminator would be jointly trained
in a game where they both strive to beat the other.
This is the approach taken by Yu et al. [15] to fine-
tune a pretrained sequence model for poem generation.
Guimaraes et al. demonstrates how such a method can
be combined with a fixed scoring function for molecular
de novo design [32].
2.5 The DRD2 activity model
In one of our studies the objective of the Agent is
to generate molecules that are predicted to be active
against a biological target. The dopamine type 2 recep-
tor DRD2 was chosen as the target, and corresponding
bioactivity data was extracted from ExCAPE-DB [33].
In this dataset there are 7218 actives (pIC50 > 5) and
343204 inactives (pIC50 < 5). A subset of 100 000 in-
active compounds was randomly selected. In order to
decrease the nearest neighbour similarity between the
training and testing structures [34–36], the actives were
grouped in clusters based on their molecular similarity.
The Jaccard [37] index, for binary vectors also known
as the Tanimoto similarity, based on the RDKit imple-
mentation of binary Extended Connectivity Molecular
Fingerprints with a diameter of 6 (ECFP6 [38]) was
used as a similarity measure and the actives were clus-
tered using the Butina clustering algorithm [39] in
RDKit with a clustering cutoff of 0.4. In this algorithm,
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Figure 5 How the model thinks while generating the molecule on the right. Conditional probability over the next token as a
function of previously chosen ones according to the model. On the y-axis is shown the probability distribution for the character to be
choosen at the current step, and on the x-axis is shown the character that in this instance was sampled. E = EOS.
centroid molecules will be selected, and everything with
a similarity higher than 0.4 to these centroids will be
assigned to the same cluster. The centroids are chosen
such as to maximize the number of molecules that are
assigned to any cluster. The clusters were sorted by
size and iteratively assigned to the test, validation, and
training sets (assigned 4 clusters each iteration) to give
a distribution of 16 ,
1
6 , and
4
6 of the clusters respectively.
The inactive compounds, of which less than 0.5% were
found to belong to any of the clusters formed by the
actives, were split randomly into the three sets using
the same ratios.
A support vector machine (SVM) classifier with a
Gaussian kernel was built in Scikit-learn [40] on the
training set as a predictive model for DRD2 activity.
The optimal C and Gamma values utilized in the final
model were obtained from a grid search for the highest
ROC-AUC performance on the validation set.
3 Results and Discussion
3.1 Structure generation by the Prior
After the initial training, 94% of the sequences gen-
erated by the Prior as described in Section 2.1.2 cor-
responded to valid molecular structures according to
RDKit [27] parsing, out of which 90% are novel struc-
tures outside of the training set. A set of randomly
chosen structures generated by the Prior, as well as by
Agents trained in the subsequent examples, are shown
in the appendix. The process of generating a SMILES
by the Prior is illustrated in Figure 5. For every token
in the generated SMILES sequence, the conditional
probability distribution over the vocabulary at this
step according to the Prior is displayed. The sequence
of distributions are depicted in Figure 5. For the first
step, when no information other than the initial GO
token is present, the distribution is an approximation
of the distribution of first tokens for the SMILES in the
ChEMBL training set. In this case ”O” was sampled,
but ”C”, ”N”, and the halogens were all likely as well.
Corresponding log likelihoods were -0.3 for ”C”, -2.7
for ”N”, -1.8 for ”O”, and -5.0 for ”F” and ”Cl”.
A few (unsurprising) observations:
• Once the aromatic ”n” has been sampled, the
model has come to expect a ring opening (i.e. a
number), since aromatic moieties by definition are
cyclic.
• Once an aromatic ring has been opened, the aro-
matic atoms ”c”, ”n”, ”o”, and ”s” become proba-
ble, until 5 or 6 steps later when the model thinks
it is time to close the ring.
• The model has learnt the RDKit canonicalized
SMILES format of increasing ring numbers, and
expects the first ring to be numbered ”1”. Ring
numbers can be reused, as in the two first rings
in this example. Only once ”1” has been sampled
does it expect a ring to be numbered ”2” and so
on.
3.2 Learning to avoid sulphur
As a proof of principle the Agent was first trained
to generate molecules which do not contain sulphur.
The method described in Section 2.4 is compared with
three other policy gradient based methods. The first
alternative method is the same as the Agent method,
with the only difference that the loss is defined on an
action basis rather than on an episodic one, resulting
in the cost function:
J(Θ) = [
T∑
t=0
(log piPrior(at, st)− log piΘ(at, st))+σS(A)]2
We refer to this method as ‘Action basis’. The second
alternative is a REINFORCE algorithm with a reward
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Table 1 Comparison of model performance and properties for non-sulphur containing structures generated by the two models. Properties
reported as Mean± StdDev.
Model Prior Agent Action basis REINFORCE REINFORCE + Prior
Fraction of valid SMILES 0.94± 0.01 0.95± 0.01 0.95± 0.01 0.98± 0.00 0.98± 0.00
Fraction without sulphur 0.66± 0.01 0.98± 0.00 0.92± 0.02 0.98± 0.00 0.92± 0.01
Average molecular weight 371± 1.70 367± 3.30 372± 0.94 585± 27.4 232± 5.25
Average cLogP 3.36± 0.04 3.37± 0.09 3.39± 0.02 11.3± 0.85 3.05± 0.02
Average NumRotBonds 5.39± 0.04 5.41± 0.07 6.08± 0.04 30.0± 2.17 2.8± 0.11
Average NumAromRings 2.26± 0.02 2.26± 0.02 2.09± 0.02 0.57± 0.04 2.11± 0.02
Table 2 Randomly selected SMILES generated by the different models.
Model Sampled SMILES
CCOC(=O)C1=C(C)OC(N)=C(C#N)C1c1ccccc1C(F)(F)F
Prior COC(=O)CC(C)=NNc1ccc(N(C)C)cc1[N+](=O)[O-]
Cc1ccccc1CNS(=O)(=O)c1ccc2c(c1)C(=O)C(=O)N2
CC(C)(C)NC(=O)c1ccc(OCc2ccccc2C(F)(F)F)nc1-c1ccccc1
Agent CC(=O)NCC1OC(=O)N2c3ccc(-c4cccnc4)cc3OCC12
OCCCNCc1cccc(-c2cccc(-c3nc4ccccc4[nH]3)c2OCCOc2ncc(Cl)cc2Br)c1
CCN1CC(C)(C)OC(=O)c2cc(-c3ccc(Cl)cc3)ccc21
Action level CCC(CC)C(=O)Nc1ccc2cnn(-c3ccc(C(C)=O)cc3)c2c1
CCCCN1C(=O)c2ccccc2NC1c1ccc(OC)cc1
CC1CCCCC12NC(=O)N(CC(=O)Nc1ccccc1C(=O)O)C2=O
REINFORCE CCCCCCCCCCCCCCCCCCCCCCCCCCCCNC(=O)OCCCCCC
CCCCCCCCCCCCCCCCCCCCCC1CCC(O)C1(CCC)CCCCCCCCCCCCCCC
Nc1ccccc1C(=O)Oc1ccccc1
REINFORCE + Prior O=c1cccccc1Oc1ccccc1
Nc1ccc(-c2ccccc2O)cc1
of S(A) given at the last step. This method is similar to
the one used by Silver et al. to train the policy network
in AlphaGo [41], as well as the method used by Yu
et al. [15]. We refer to this method as ‘REINFORCE’.
The corresponding cost function can be written as:
J(Θ) = S(A)
T∑
t=0
log piΘ(at, st)
A variation of this method that considers prior likeli-
hood is defined by changing the reward from S(A) to
S(A) + logP (A)Prior. This method is referred to as
‘REINFORCE + Prior’, with the cost function:
J(Θ) = [logP (A)Prior + σS(A)]
T∑
t=0
log piΘ(at, st)
Note that the last method by nature strives to generate
only the putative sequence with the highest reward.
In contrast to the Agent, the optimal policy for this
method is not stochastic. This tendency could be re-
strained by introducing a regularizing policy entropy
term. However, it was found that such regularization un-
dermined the models ability to produce valid SMILES.
This method is therefor dependent on only training
sufficiently long for the model to reach a point where
highly scored sequences are generated, without being
settled in a local minima. The experiment aims to
answer the following questions:
• Can the models achieve the task of generating
valid SMILES corresponding to structures that do
not contain sulphur?
• Will the models exploit the reward function by
converging on na¨ıve solutions such as ’C’ if not
imposed handwritten rules?
• Are the distributions of physical chemical proper-
ties for the generated structures similar to those
of sulphur free structures generated by the Prior?
The task is defined by the following scoring function:
S(A) =

1 if valid and no S
0 if not valid
−1 if contains S
All the models were trained for 1000 steps starting from
the Prior and 12800 SMILES sequences were sampled
from all the models as well as the Prior. A learning
rate of 0.0005 was used for the Agent and Action basis
methods, and 0.0001 for the two REINFORCE meth-
ods. The values of σ used were 2 for the Agent and
’REINFORCE + Prior’, and 8 for ’Action basis’. To
explore what effect the training has on the structures
generated, relevant properties for non sulphur contain-
ing structures generated by both the Prior and the
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other models were compared. The molecular weight,
cLogP, the number of rotatable bonds, and the num-
ber of aromatic rings were all calculated using RDKit.
The experiment was repeated three times with differ-
ent random seeds. The results are shown in Table 1
and randomly selected SMILES generated by the Prior
and the different models can be seen in Table 2. For
the ’REINFORCE’ method, where the sole aim is to
generate valid SMILES that do not contain sulphur,
the model quickly learns to exploit the reward fun-
tion by generating sequences containing predominately
‘C‘. This is not surprising, since any sequence consist-
ing only of this token always gets rewarded. For the
’REINFORCE + Prior’ method, the inclusion of the
prior likelihood in the reward function means that this
is no longer a viable strategy (the sequences would
be given a low prior probability). The model instead
tries to find the structure with the best combination
of score and prior likelihood, but as is evident from
the SMILES generated and the statistics shown in Ta-
ble 1, this results in small, simplistic structures being
generated. Thus, both REINFORCE algorithms man-
aged to achieve high scores according to the scoring
function, but poorly represented the Prior. Both the
Agent and the ’Action basis’ methods have explicitly
specified target policies. For the ’Action basis’ method
the policy is specified exactly on a stepwise level, while
for the Agent the target policy is only specified to the
likelihoods of entire sequences. Although the ’Action
basis’ method generates structures that are more simi-
lar to the Prior than the two REINFORCE methods,
it performed worse than the Agent despite the higher
value of σ used while also being slower to learn. This
may be due to the less restricted target policy of the
Agent, which could facilitate optimization. The Agent
achieved the same fraction of sulphur free structures
as the REINFORCE algorithms, while seemingly do-
ing a much better job of representing the Prior. This
is indicated by the similarity of the properties of the
generated structures shown in Table 1 as well as the
SMILES themselves shown in Table 2.
3.3 Similarity guided structure generation
The second task investigated was that of generating
structures similar to a query structure. The Jaccard
index [37] Ji,j of the RDKit implementation of FCFP4
[38] fingerprints was used as a similarity measure be-
tween molecules i and j. Compared to the DRD2 activ-
ity model (Section 2.5), the feature invariant version of
the fingerprints and the smaller diameter 4 was used
in order to get a more fuzzy similarity measure. The
scoring function was defined as:
S(A) = −1 + 2× min{Ji,j , k}
k
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Figure 6 Average similarity J of generated structures as a
function of training steps. Difference in learning dynamics for
the Agents based on the canonical Prior, and those based on a
reduced Prior where everything more similar than J = 0.5 to
Celecoxib have been removed.
This definition means that an increase in similarity is
only rewarded up to the point of k ∈ [0, 1], as well
as scaling the reward from −1 (no overlap in the fin-
gerprints between query and generated structure) to 1
(at least k degree of overlap). Celecoxib was chosen as
our query structure, and we first investigated whether
Celecoxib itself could be generated by using the high
values of k = 1 and σ = 15. The Agent was trained
for 1000 steps. After a 100 training steps the Agent
starts to generate Celecoxib, and after 200 steps it
predominately generates this structure (Figure 6).
Celecoxib itself as well as many other similar struc-
tures appear in the ChEMBL training set used to build
the Prior. An interesting question is whether the Agent
could succeed in generating Celecoxib when these struc-
tures are not part of the chemical space covered by the
Prior. To investigate this, all structures with a similar-
ity to Celecoxib higher than 0.5 (corresponding to 1804
molecules) were removed from the training set and a
new reduced Prior was trained. The prior likelihood
of Celecoxib for the canonical and reduced Priors was
compared, as well as the ability of the models to gener-
ate structures similar to Celecoxib. As expected, the
prior probability of Celecoxib decreased when similar
compounds were removed from the training set from
loge P = −12.7 to loge P = −19.2, representing a re-
duction in likelihood of a factor of 700. An Agent was
then trained using the same hyperparameters as before,
but on the reduced Prior. After 400 steps, the Agent
again managed to find Celecoxib, albeit requiring more
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Figure 7 Evolution of generated structures during training Structures sampled every 100 training steps during the training of the
Agent towards similarity to Celecoxib with k = 0.7 and σ = 15.
time to do so. After 1000 steps, Celecoxib was the
most commonly generated structure (about a third of
the generated structures), followed by demethylated
Celecoxib (also a third) whose SMILES is more likely
according to the Prior with loge P = −15.2 but has a
lower similarity (J = 0.87), resulting in an augmented
likelihood equal to that of Celecoxib.
These experiments demonstrate that the Agent can
be optimized using fingerprint based Jaccard similarity
as the objective, but making copies of the query struc-
ture is hardly useful. A more useful example is that of
generating structures that are moderately to the query
structure. The Agent was therefore trained for 3000
steps, starting from both the canonical as well as the
reduced Prior, using k = 0.7 and σ = 12. The Agents
based on the canonical Prior quickly converge to their
targets, while the Agents based on the reduced Prior
converged more slowly. For the Agent based on the
reduced Prior where k = 1, the fact that Celecoxib and
demethylated Celecoxib are given similar augmented
likelihoods means that the average similarity converges
to around 0.9 rather than 1.0. For the Agent based on
the reduced Prior where k = 0.7, the lower prior likeli-
hood of compounds similar to Celecoxib translates to a
lower augmented likelihood, which lowers the average
similarity of the structures generated by the Agent.
To explore whether this reduced prior likelihood could
be offset with a higher value of σ, an Agent start-
ing from the reduced Prior was trained using σ = 15.
Though taking slightly more time to converge than the
Olivecrona et al. Page 10 of 19
Agent based on the canonical Prior, this Agent too
could converge to the target similarity. The learning
curves for the different model is shown in Figure 6.
An illustration of how the type of structures generated
by the Agent evolves during training is shown in Figure
7. For the Agent based on the reduced Prior with k =
0.7 and σ = 15, three structures were randomly sampled
every 100 training steps from step 0 up to step 400. At
first, the structures are not similar to Celecoxib. After
200 steps, some features from Celecoxib have started to
emerge, and after 300 steps the model generates mostly
close analogues of Celecoxib.
We have investigated how various factors affect the
learning behaviour of the Agent. In real drug discov-
ery applications, we might be more interested in find-
ing structures with modest similarity to our query
molecules rather than very close analogues. For exam-
ple, one of the structures sampled after 200 steps shown
in Figure 7 displays a type of scaffold hopping where
the sulphur functional group on one of the outer aro-
matic rings has been fused to the central pyrazole. The
similarity to Celecoxib of this structure is 0.4, which
may be a more interesting solution for scaffold-hopping
purposes. One can choose hyperparameters and simi-
larity criterion tailored to the desired output. Other
types of similarity measures such as pharmacophoric
fingerprints [42], Tversky substructure similarity [43],
or presence/absence of certain pharmacophores could
also be explored.
3.4 Target activity guided structure generation
The third example, perhaps the one most interesting
and relevant for drug discovery, is to optimize the Agent
towards generating structures with predicted biological
activity. This can be seen as a form of inverse QSAR,
where the Agent is used to implicitly map high pre-
dicted probability of activity to molecular structure.
DRD2 was chosen as the biological target. The clus-
tering split of the DRD2 activity dataset as described
in Section 2.5 resulted in 1405, 1287, and 4526 actives
in the test, validation, and training sets respectively.
The average similarity to the nearest neighbour in the
training set for the test set compounds was 0.53. For
a random split of actives in sets of the same sizes this
similarity was 0.69, indicating that the clustering had
significantly decreased training-test set similarity which
mimics the hit finding practice in drug discovery to
identify diverse hits to the training set. Most of the
DRD2 actives are also included in the ChEMBL dataset
used to train the Prior. To explore the effect of not hav-
ing the known actives included in the Prior, a reduced
Prior was trained on a reduced subset of the ChEMBL
training set where all DRD2 actives had been removed.
The optimal hyperparameters found for the SVM
activity model were C = 27, γ = 2−6, resulting in a
Table 3 Performance of the DRD2 activity model
Set Training Validation Test
Accuracy 1.00 0.98 0.98
ROC-AUC 1.00 0.99 1.00
Precision 1.00 0.96 0.97
Recall 1.00 0.73 0.82
model whose performance is shown in Table 3. The
good performance in general can be explained by the
apparent difference between actives and inactive com-
pounds as seen during the clustering, and the better
performance on the test set compared to the validation
set could be due to slightly higher nearest neighbour
similarity to the training actives (0.53 for test actives
and 0.48 for validation actives).
The output of the DRD2 model for a given structure
is an uncalibrated predicted probability of being active
Pactive. This value is used to formulate the following
scoring function:
S(A) = −1 + 2× Pactive
The model was trained for 3000 steps using σ = 7. After
training, the fraction of predicted actives according to
the DRD2 model increased from 0.02 for structures
generated by the reduced Prior to 0.96 for structures
generated by the corresponding Agent network (Table
4). To see how well the structure-activity-relationship
learnt by the activity model is transferred to the type of
structures generated by the Agent RNN, the fraction of
compounds with an ECFP6 Jaccard similarity greater
than 0.4 to any active in the training and test sets was
calculated.
In some cases, the model recovered exact matches
from the training and test sets (c.f. Segler et al. [13]).
The fraction of recovered test actives recovered by the
canonical and reduced Prior were 1.3% and 0.3% re-
spectively. The Agent derived from the canonical Prior
managed to recover 13% test actives; the Agent derived
from the reduced Prior recovered 7%. For the Agent de-
rived from the reduced Prior, where the DRD2 actives
were excluded from the Prior training set, this means
that the model has learnt to generate ”novel” struc-
tures that have been seen neither by the DRD2 activity
model nor the Prior, and are experimentally confirmed
actives. We can formalize this observation by calcu-
lating the probability of a given generated sequence
belonging to the set of test actives. For the canoni-
cal and reduced Priors, this probability was 0.17×10−3
and 0.05×10−3 respectively. Removing the actives from
the Prior thus resulted in a threefold reduction in the
probability of generating a structure from the set of
test actives. For the Agents, the probabilities rose to
15.0×10−3 and 40.2×10−3 respectively, corresponding
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Table 4 Comparison of properties for structures generated by the canonical Prior, the reduced Prior, and corresponding Agents.
Model Prior Agent Prior† Agent†
Fraction valid SMILES 0.94 0.99 0.94 0.99
Fraction predicted actives 0.03 0.97 0.02 0.96
Fraction similar to train active 0.02 0.79 0.02 0.75
Fraction similar to test active 0.01 0.46 0.01 0.38
Fraction of test actives recovered (×10−3) 13.5 126 2.85 72.6
Probability of generating a test set active (×10−3) 0.17 40.2 0.05 15.0
†DRD2 actives witheld from the training of the Prior
Recovered test actives
Pactive 0.95 0.95 0.73 0.66
Randomly selected
Pactive 1.00 0.99 0.98 1.00
Figure 8 Structures designed by the Agent to target DRD2. Molecules generated by the Agent based on the reduced Prior. On the
top are four of the test set actives that were recovered, and below are four randomly selected structures. The structures are annotated
with the predicted probability of being active.
to an enrichment of a factor of 250 over the Prior
models. Again the consequence of removing the actives
from the Prior was a threefold reduction in the prob-
ability of generating a test set active: the difference
between the two Priors is directly mirrored by their
corresponding Agents. Apart from generating a higher
fraction of structures that are predicted to be active,
both Agents also generate a significantly higher frac-
tion of valid SMILES (Table 4). Sequences that are
not valid SMILES receive a score of -1, which means
that the scoring function naturally encourages valid
SMILES.
A few of the test set actives generated by the Agent
based on the reduced Prior along with a few randomly
selected generated structures are shown together with
their predicted probability of activity in Figure 8. En-
couragingly, the recovered test set actives vary consid-
erably in their structure, which would not have been
the case had the Agent converged to generating only
a certain type of very similar predicted active com-
pounds.
Removing the known actives from the training set of
the Prior resulted in an Agent which shows a decrease
in all metrics measuring the overlap between the known
actives and the structures generated, compared to the
Agent derived from the canonical Prior. Interestingly,
the fraction of predicted actives did not change signifi-
cantly. This indicates that the Agent derived from the
reduced Prior has managed to find a similar chemical
space to that of the canonical Agent, with structures
that are equally likely to be predicted as active, but are
less similar to the known actives. Whether or not these
compounds are active will be dependent on the accu-
racy of the target activity model. Ideally, any predictive
model to be used in conjunction with the generative
model should cover a broad chemical space within its
domain of applicability, since it initially has to assess
representative structures of the dataset used to build
the Prior [13].
Figure 9 shows a comparison of the conditional prob-
ability distributions for the reduced Prior and its cor-
responding Agent when a molecule from the set of test
actives is generated. It can be seen that the changes
are not drastic with most of the trends learnt by the
Prior being carried over to the Agent. However, a big
change in the probability distribution even only at
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Figure 9 A (small) change of mind. The conditional probability distributions when the DRD2 test set active
’COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2I)CC1’ is generated by the Prior and an Agent trained using the DRD2 activity model, for
the case where all actives used to build the activity model have been removed from the Prior. E = EOS.
one step can have a large impact on the likelihood of
the sequence and could significantly alter the type of
structures generated.
4 Conclusion
To summarize, we believe that an RNN operating on
the SMILES representation of molecules is a promising
method for molecular de novo design. It is a data-driven
generative model that does not rely on pre-defined
building blocks and rules, which makes it clearly dif-
ferentiated from traditional methods. In this study we
extend upon previous work [13–15, 17] by introducing
a reinforcement learning method which can be used to
tune the RNN to generate structures with certain desir-
able properties through augmented episodic likelihood.
The model was tested on the task of generating sul-
phur free molecules as a proof of principle, and the
method using augmented episodic likelihood was com-
pared with traditional policy gradient methods. The
results indicate that the Agent can find solutions re-
flecting the underlying probability distribution of the
Prior, representing a significant improvement over both
traditional REINFORCE [30] algorithms as well as
previously reported methods [17]. To evaluate if the
model could be used to generate analogues to a query
structure, the Agent was trained to generate structures
similar to the drug Celecoxib. Even when all analogues
of Celecoxib were removed from the Prior, the Agent
could still locate the intended region of chemical space
which was not part of the Prior. Further more, when
trained towards generating predicted actives against
the dopamine receptor type 2 (DRD2), the Agent gen-
erates structures of which more than 95% are predicted
to be active, and could recover test set actives even
in the case where they were not included in either the
activity model nor the Prior. Our results indicate that
the method could be a useful tool for drug discovery.
It is clear that the qualities of the Prior are reflected
in the corresponding Agents it produces. An exhaustive
study which explores how parameters such as train-
ing set size, model size, regularization [44, 45], and
training time would influence the quality and variety of
structures generated by the Prior would be interesting.
Another interesting avenue for future research might be
that of token embeddings [46]. The method was found
to be robust with respect to the hyperparameters σ
and the learning rate.
All of the aforementioned examples used single param-
eter based scoring functions. In a typical drug discovery
project, multiple parameters such as target activity,
DMPK profile, synthetic accessibility etc. all need to
be taken into account simultaneously. Applying this
type of multi-parametric scoring functions to the model
is an area requiring further research.
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1 Additional File 1.
Here is shown how the cost function of the form J(θ) = [logP (A)A− logP (A)U]2 can
be expressed as a REINFORCE algorithm with a single point estimate of the return
G(at, st) = [logP (A)A − logP (A)U]2/ logP (A)A. A REINFORCE type algorithm for
an episode {s0, a0, r0, ..., sT , aT , rT} following the stochastic policy piθ is described by
the update rule:
θ = θ − α∇θ
T∑
t=0
log piθ(at | st)(G(at, st)− b)
Where α in this case is the step size, b is the reward baseline, and G(at, st) =∑T
t (rt) is the observed cumulative reward from time t until the end of the episode.
In a REINFORCE algorithm this single sampled trajectory serves as an unbiased
estimator of the expected cumulative reward. If we use a zero baseline b = 0, this is
equivalent to the cost function:
J(θ) =
T∑
t=0
log piθ(at | st)G(at, st)
If we define the reward for any state-action pair during the episode as equal to 0
except for the last step where it is G(A), this expression can be written as:
∀t ∈ [0, ..., T ], G(at, st) =
T∑
t
(rt) = G(A)
The cost function becomes:
J(θ) =
T∑
t=0
log piθ(at | st)G(at, st) = G(A)
T∑
t=0
log piθ(at | st)
We now note that the sum
∑T
t=0 log piθ(at | st) is equal to the Agent likelihood for
the sequence:
J(θ) = G(A)
T∑
t=0
log piθ(at | st) = G(A) logP (A)A
If we choose the reward for the final step of the sequence A to be G(A) =
[logP (A)A − logP (A)U]2/ logP (A)A, we recover our initial cost function:
J(θ) =
[logP (A)A − logP (A)U]2
logP (A)A
logP (A)A = [logP (A)A − logP (A)U]2

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Figure 10 Additional file 2.1 Randomly selected structures generated by the canonical Prior.
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Figure 11 Additional file 2.2 Randomly selected structures generated by the Agent trained to avoid sulphur.
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Figure 12 Additional file 2.3 Randomly selected structures generated by the Agent based on the reduced Prior trained to design
analogues of Celecoxib.
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Figure 13 Additional file 2.4 Randomly selected structures generated by the Agent based on the reduced Prior trained to design
actives against DRD2.
